Fund shareholders of Bridgebio Pharma Inc
ISIN US10806X1028 · United States · LEI 54930028YG89VTY2J114
- Fund shareholders
- 455
- Of which ETFs
- 81 374 other funds
- Value held
- 5B $ 330.7M SEK · 167.2K €
- Share of capital
- 35.2 % of 195.5M shares on Aug 3, 2026
455 funds hold this company. This table lists the 454 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. It is not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 5,557,828 | 412.7M $ | 0.02 % | 2.84 % | as of Mar 31, 2026 ↗ |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 4,022,939 | 298.7M $ | 0.18 % | 2.06 % | as of Mar 31, 2026 ↗ |
| iShares Russell 2000 ETF iShares Trust | 3,877,396 | 287.9M $ | 0.40 % | 1.98 % | as of Mar 31, 2026 ↗ |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 2,251,189 | 167.2M $ | 0.43 % | 1.15 % | as of Mar 31, 2026 ↗ |
| Janus Henderson Enterprise Fund JANUS INVESTMENT FUND | 1,909,659 | 141.8M $ | 0.69 % | 0.98 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,893,232 | 140.6M $ | 0.17 % | 0.97 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 1,568,559 | 111.5M $ | 0.34 % | 0.80 % | as of Apr 30, 2026 ↗ |
| Janus Henderson Global Life Sciences Fund JANUS INVESTMENT FUND | 1,551,141 | 115.2M $ | 2.22 % | 0.79 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXPLORER FUND VANGUARD EXPLORER FUND | 1,391,279 | 98.9M $ | 0.45 % | 0.71 % | as of Apr 30, 2026 ↗ |
| iShares Russell 2000 Growth ETF iShares Trust | 1,294,072 | 96.1M $ | 0.79 % | 0.66 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 1,238,687 | 92M $ | 1.13 % | 0.63 % | as of Mar 31, 2026 ↗ |
| Nomura Small Cap Core Fund Delaware Group Equity Funds V | 1,199,249 | 79.7M $ | 1.39 % | 0.61 % | as of Feb 27, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 1,186,816 | 88.1M $ | 1.19 % | 0.61 % | as of Mar 31, 2026 ↗ |
| Invesco Discovery Fund AIM Counselor Series Trust (Invesco Counselor Series Trust) | 1,107,506 | 73.6M $ | 1.11 % | 0.57 % | as of Feb 28, 2026 ↗ |
| VANGUARD HEALTH CARE FUND VANGUARD SPECIALIZED FUNDS | 982,977 | 69.9M $ | 0.19 % | 0.50 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 906,623 | 67.3M $ | 0.82 % | 0.46 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 887,690 | 59M $ | 0.14 % | 0.45 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 864,149 | 64.2M $ | 0.59 % | 0.44 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 850,480 | 63.2M $ | 0.49 % | 0.44 % | as of Mar 31, 2026 ↗ |
| Small Cap Growth Fund American Century Mutual Funds, Inc. | 824,499 | 58.6M $ | 1.16 % | 0.42 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 823,110 | 54.7M $ | 0.26 % | 0.42 % | as of Feb 28, 2026 ↗ |
| Janus Henderson Triton Fund JANUS INVESTMENT FUND | 801,169 | 59.5M $ | 1.15 % | 0.41 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 786,269 | 52.3M $ | 0.34 % | 0.40 % | as of Feb 28, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 707,304 | 47M $ | 0.88 % | 0.36 % | as of Feb 28, 2026 ↗ |
| Hood River Small-Cap Growth Fund Manager Directed Portfolios | 684,355 | 50.8M $ | 0.98 % | 0.35 % | as of Mar 31, 2026 ↗ |
| SMALLCAP World Fund Inc SMALLCAP World Fund Inc | 681,290 | 50.6M $ | 0.06 % | 0.35 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Growth Fund Fidelity Securities Fund | 673,269 | 47.9M $ | 0.57 % | 0.34 % | as of Apr 30, 2026 ↗ |
| Janus Henderson Venture Fund JANUS INVESTMENT FUND | 615,777 | 45.7M $ | 1.49 % | 0.31 % | as of Mar 31, 2026 ↗ |
| Franklin Dynatech Fund Franklin Custodian Funds | 600,000 | 44.6M $ | 0.18 % | 0.31 % | as of Mar 31, 2026 ↗ |
| Columbia Small Cap Growth Fund COLUMBIA FUNDS SERIES TRUST I | 592,147 | 39.4M $ | 1.23 % | 0.30 % | as of Feb 28, 2026 ↗ |
| LORD ABBETT DEVELOPING GROWTH FUND INC LORD ABBETT DEVELOPING GROWTH FUND, INC. | 554,755 | 39.4M $ | 1.78 % | 0.28 % | as of Apr 30, 2026 ↗ |
| AB Small Cap Growth Portfolio AB CAP FUND, INC. | 472,386 | 33.6M $ | 1.15 % | 0.24 % | as of Apr 30, 2026 ↗ |
| Fidelity SAI Small-Mid Cap Momentum Index Fund Fidelity Salem Street Trust | 469,647 | 33.4M $ | 0.78 % | 0.24 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Mid-Cap ETF SCHWAB STRATEGIC TRUST | 457,985 | 30.4M $ | 0.22 % | 0.23 % | as of Feb 28, 2026 ↗ |
| SmallCap Fund Principal Funds, Inc | 448,200 | 31.9M $ | 1.52 % | 0.23 % | as of Apr 30, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 437,130 | 32.5M $ | 2.04 % | 0.22 % | as of Mar 31, 2026 ↗ |
| Invesco Main Street Small Cap Fund AIM Growth Series (Invesco Growth Series) | 434,199 | 32.2M $ | 1.46 % | 0.22 % | as of Mar 31, 2026 ↗ |
| Putnam Small Cap Growth Fund Putnam Funds Trust | 430,723 | 32M $ | 1.18 % | 0.22 % | as of Mar 31, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 430,304 | 28.6M $ | 0.14 % | 0.22 % | as of Feb 28, 2026 ↗ |
| Franklin Small Cap Growth Fund Franklin Strategic Series | 429,950 | 30.6M $ | 1.25 % | 0.22 % | as of Apr 30, 2026 ↗ |
| JNL/Invesco Small Cap Growth Fund JNL Series Trust | 397,288 | 29.5M $ | 1.90 % | 0.20 % | as of Mar 31, 2026 ↗ |
| Janus Henderson Research Fund JANUS INVESTMENT FUND | 396,241 | 29.4M $ | 0.12 % | 0.20 % | as of Mar 31, 2026 ↗ |
| Invesco Small Cap Growth Fund AIM Growth Series (Invesco Growth Series) | 396,188 | 29.4M $ | 1.90 % | 0.20 % | as of Mar 31, 2026 ↗ |
| PRIMECAP Odyssey Aggressive Growth Fund PRIMECAP Odyssey Funds | 391,400 | 27.8M $ | 0.41 % | 0.20 % | as of Apr 30, 2026 ↗ |
| AB DISCOVERY GROWTH FUND, INC. AB DISCOVERY GROWTH FUND, INC. | 370,443 | 26.3M $ | 0.98 % | 0.19 % | as of Apr 30, 2026 ↗ |
| ClearBridge Small Cap Growth Fund Legg Mason Partners Investment Trust | 359,557 | 25.6M $ | 1.28 % | 0.18 % | as of Apr 30, 2026 ↗ |
| Schwab Small-Cap Index Fund SCHWAB CAPITAL TRUST | 348,001 | 24.7M $ | 0.34 % | 0.18 % | as of Apr 30, 2026 ↗ |
| Fidelity Small Cap Growth K6 Fund Fidelity Securities Fund | 336,522 | 23.9M $ | 0.56 % | 0.17 % | as of Apr 30, 2026 ↗ |
| Bridge Builder Small/Mid Cap Growth Fund Bridge Builder Trust | 332,330 | 24.7M $ | 0.27 % | 0.17 % | as of Mar 31, 2026 ↗ |
| JPMorgan Mid Cap Growth Fund JPMorgan Trust II | 330,683 | 24.6M $ | 0.22 % | 0.17 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 317,784 | 21.1M $ | 0.02 % | 0.16 % | as of Feb 28, 2026 ↗ |
| Columbia Acorn Fund COLUMBIA ACORN TRUST | 316,495 | 23.5M $ | 1.05 % | 0.16 % | as of Mar 31, 2026 ↗ |
| Allspring Growth Fund ALLSPRING FUNDS TRUST | 286,074 | 20.3M $ | 0.65 % | 0.15 % | as of Apr 30, 2026 ↗ |
| Voya Small Cap Growth Fund Voya Equity Trust | 274,617 | 18.3M $ | 0.99 % | 0.14 % | as of Feb 28, 2026 ↗ |
| SmallCap Growth Fund I Principal Funds, Inc | 267,739 | 19M $ | 0.81 % | 0.14 % | as of Apr 30, 2026 ↗ |
| Master Small Cap Index Series Quantitative Master Series LLC | 257,905 | 19.2M $ | 0.40 % | 0.13 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 251,150 | 16.7M $ | 0.02 % | 0.13 % | as of Feb 28, 2026 ↗ |
| Invesco Main Street Mid Cap Fund AIM Growth Series (Invesco Growth Series) | 249,297 | 18.5M $ | 0.78 % | 0.13 % | as of Mar 31, 2026 ↗ |
| JPMorgan Small Cap Growth Fund JPMorgan Trust II | 243,638 | 18.1M $ | 0.83 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 241,119 | 17.1M $ | 1.66 % | 0.12 % | as of Apr 30, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 237,042 | 15.8M $ | 0.02 % | 0.12 % | as of Feb 28, 2026 ↗ |
| SEB Läkemedelsfond SEB Funds AB | 235,813 | 166.8M SEK | 1.03 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Invesco V.I. Main Street Small Cap Fund AIM Variable Insurance Funds (Invesco Variable Insurance Funds) | 229,024 | 17M $ | 1.45 % | 0.12 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 220,050 | 16.3M $ | 0.02 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Invesco Health Care Fund AIM Investment Funds (Invesco Investment Funds) | 216,227 | 15.4M $ | 1.36 % | 0.11 % | as of Apr 30, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 204,874 | 13.6M $ | 0.21 % | 0.10 % | as of Feb 27, 2026 ↗ |
| Invesco Small Cap Growth Portfolio Brighthouse Funds Trust I | 200,294 | 14.9M $ | 1.89 % | 0.10 % | as of Mar 31, 2026 ↗ |
| EQ/AB Small Cap Growth Portfolio EQ Advisors Trust | 190,060 | 14.1M $ | 0.74 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Nuveen Small Cap Blend Index Fund TIAA-CREF Funds | 189,048 | 13.4M $ | 0.34 % | 0.10 % | as of Apr 30, 2026 ↗ |
| Fidelity Enhanced Small Cap ETF Fidelity Covington Trust | 187,834 | 13.9M $ | 0.34 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Principal U.S. Small-Cap ETF Principal Exchange-Traded Funds | 175,240 | 13M $ | 0.74 % | 0.09 % | as of Mar 31, 2026 ↗ |
| BlackRock Advantage Small Cap Core Fund BlackRock Funds | 173,076 | 11.5M $ | 0.25 % | 0.09 % | as of Feb 27, 2026 ↗ |
| Invesco Small Cap Equity Fund AIM Funds Group (Invesco Funds Group) | 171,349 | 12.7M $ | 1.25 % | 0.09 % | as of Mar 31, 2026 ↗ |
| EQ/2000 Managed Volatility Portfolio EQ Advisors Trust | 165,860 | 12.3M $ | 0.36 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Small/Mid Cap Growth Fund Goldman Sachs Trust | 165,277 | 11M $ | 0.90 % | 0.08 % | as of Feb 28, 2026 ↗ |
| Driehaus Small Cap Growth Fund Driehaus Mutual Funds | 164,124 | 12.2M $ | 1.06 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Federated Hermes MDT Small Cap Core Fund Federated Hermes MDT Series | 163,560 | 11.6M $ | 0.61 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Victory Science & Technology Fund Victory Portfolios III | 161,195 | 11.5M $ | 0.81 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Janus Henderson Enterprise Portfolio JANUS ASPEN SERIES | 158,733 | 11.8M $ | 0.70 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Artisan International Small-Mid Fund Artisan Partners Funds Inc. | 157,803 | 11.7M $ | 0.44 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Small Cap Dynamic Growth Fund John Hancock Funds II | 153,710 | 10.2M $ | 1.97 % | 0.08 % | as of Feb 28, 2026 ↗ |
| Janus Henderson Small/Mid Cap Growth Alpha ETF Janus Detroit Street Trust | 145,924 | 10.4M $ | 1.06 % | 0.07 % | as of Apr 30, 2026 ↗ |
| VANGUARD RUSSELL 2000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 145,397 | 9.7M $ | 0.67 % | 0.07 % | as of Feb 28, 2026 ↗ |
| Emerald Growth Fund FINANCIAL INVESTORS TRUST | 142,057 | 10.1M $ | 0.72 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 132,364 | 9.4M $ | 0.02 % | 0.07 % | as of Apr 30, 2026 ↗ |
| iShares U.S. Small-Cap Equity Factor ETF iShares Trust | 132,275 | 9.4M $ | 0.26 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Allspring Premier Large Company Growth Fund ALLSPRING FUNDS TRUST | 130,787 | 9.3M $ | 0.69 % | 0.07 % | as of Apr 30, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 129,850 | 9.2M $ | 0.01 % | 0.07 % | as of Apr 30, 2026 ↗ |
| First Trust US Equity Opportunities ETF First Trust Exchange-Traded Fund | 127,205 | 9.4M $ | 0.81 % | 0.07 % | as of Mar 31, 2026 ↗ |
| EQ/Janus Enterprise Portfolio EQ Advisors Trust | 124,745 | 9.3M $ | 0.69 % | 0.06 % | as of Mar 31, 2026 ↗ |
| JNL Multi-Manager Small Cap Growth Fund JNL Series Trust | 123,177 | 9.1M $ | 0.46 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Small Cap Growth Stock Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 121,026 | 9M $ | 1.23 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Growth Index Fund Fidelity Salem Street Trust | 120,643 | 9M $ | 0.79 % | 0.06 % | as of Mar 31, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 119,252 | 8.9M $ | 0.01 % | 0.06 % | as of Mar 31, 2026 ↗ |
| T.Rowe Price Small Cap Growth Portfolio Brighthouse Funds Trust II | 116,718 | 8.7M $ | 0.82 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 114,318 | 7.6M $ | 4.75 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 112,823 | 7.5M $ | 0.03 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 106,480 | 7.6M $ | 0.02 % | 0.05 % | as of Apr 30, 2026 ↗ |
| LVIP SSGA Small-Cap Index Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 104,985 | 7.8M $ | 0.40 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Royce Small-Cap Fund ROYCE FUND | 104,260 | 7.7M $ | 0.43 % | 0.05 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 5.75 % | as of Mar 31, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 4.75 % | as of Feb 28, 2026 ↗ |
| Franklin Genomic Advancements ETF Franklin Templeton ETF Trust | 4.22 % | as of Mar 31, 2026 ↗ |
| F/m Emerald Life Sciences Innovation ETF RBB Fund, Inc. | 2.56 % | as of Feb 28, 2026 ↗ |
| SIMT Small Cap Growth Fund SEI INSTITUTIONAL MANAGED TRUST | 2.43 % | as of Mar 31, 2026 ↗ |
| Victory RS Select Growth Fund Victory Portfolios | 2.27 % | as of Mar 31, 2026 ↗ |
| Tema Heart & Health ETF Tema ETF Trust | 2.23 % | as of Feb 28, 2026 ↗ |
| Janus Henderson Global Life Sciences Fund JANUS INVESTMENT FUND | 2.22 % | as of Mar 31, 2026 ↗ |
| Developing Growth Portfolio LORD ABBETT SERIES FUND INC | 2.21 % | as of Mar 31, 2026 ↗ |
| NICHOLAS PARTNERS SMALL CAP GROWTH FUND ADVISORS' INNER CIRCLE III | 2.15 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 448 | +35 | 68,423,703 | +4.7 % |
| 2026Q1 | 413 | +58 | 65,336,428 | +9.0 % |
| 2025Q4 | 355 | +35 | 59,967,793 | +4.5 % |
| 2025Q3 | 320 | +41 | 57,383,094 | +13.0 % |
| 2025Q2 | 279 | +44 | 50,770,124 | +7.7 % |
| 2025Q1 | 235 | -11 | 47,152,884 | +8.5 % |
| 2024Q4 | 246 | -24 | 43,448,131 | +2.9 % |
| 2024Q3 | 270 | -6 | 42,238,206 | +3.2 % |
| 2024Q2 | 276 | +15 | 40,932,145 | +1.2 % |
| 2024Q1 | 261 | +33 | 40,458,314 | +18.0 % |
| 2023Q4 | 228 | 34,283,131 |
Institutional managers
449 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 14,207,757 | 1.1B $ | as of Mar 31, 2026 |
| Kohlberg Kravis Roberts & Co. L.P. | 13,260,971 | 984.8M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 13,179,013 | 978.6M $ | as of Mar 31, 2026 |
| VIKING GLOBAL INVESTORS LP | 11,842,434 | 879.4M $ | as of Mar 31, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | 9,365,463 | 695.5M $ | as of Mar 31, 2026 |
| Aisling Capital Management LP | 5,089,611 | 378M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 4,934,320 | 366.4M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 4,918,030 | 371.9M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 4,592,814 | 341.1M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3,801,655 | 282.3K $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 3,448,139 | 256.1M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 3,173,940 | 235.7M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 3,120,631 | 231.7M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 2,545,486 | 189M $ | as of Mar 31, 2026 |
| Polar Capital Holdings Plc | 2,519,306 | 187.1M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 2,483,953 | 184.5M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 2,438,925 | 181.1M $ | as of Mar 31, 2026 |
| FMR LLC | 2,343,754 | 174M $ | as of Mar 31, 2026 |
| UBS Group AG | 2,026,821 | 150.5M $ | as of Mar 31, 2026 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 1,977,080 | 146.8M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,976,094 | 146.7M $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 1,908,907 | 146M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,897,716 | 140.9M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,877,359 | 139.4M $ | as of Mar 31, 2026 |
| SC US (TTGP), LTD. | 1,860,364 | 138.2M $ | as of Mar 31, 2026 |
Declared shareholders of Bridgebio Pharma Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 6.80 % | 13,179,013 | as of Mar 31, 2026 · SCHEDULE 13G |
| VIKING GLOBAL INVESTORS LP and 6 others | 6.10 % | 11,842,434 | as of Mar 31, 2026 · SCHEDULE 13D |
| Farallon Capital Partners, L.P. and 27 others | 5.20 % | 10,226,063 | as of May 22, 2026 · SCHEDULE 13G |
Funds holding the debt of Bridgebio Pharma Inc
56 funds declare 89 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of Bridgebio Pharma Inc". https://titelia.com/en/stocks/bridgebio-pharma-inc-US10806X1028